Home
Conditions
Hepatitis, Viral, Human

Clinical trial condition

Hepatitis, Viral, Human

Explore clinical trials studying Hepatitis, Viral, Human. Study availability and eligibility vary by location and protocol.

2,914 public trials 161 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis, Viral, Human trial results

Completed

Study of HIV, HCV, APS and Phylogenetics for PWID

NCT03447210

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +20 more
Locations: Githurai Drop-in Centre Nairobi, Kenya

Ngara Health Centre Nairobi, Kenya

Pangani Drop-in Centre Nairobi, Kenya

View Trial Details

Completed

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

NCT01519960

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Univ of California SF, Benioff Children's Hospital; Pediatrics, Gastro, Hepatology & Nutrition San Francisco, California, United States

Johns Hopkins Hospital - Pediatric Gastroenterology Baltimore, Maryland, United States

Children's Hospital Boston-Harvard Medical School; Division of Gastoenterology Boston, Massachusetts, United States

St. Louis University - Cardinal Glennon Children's Medical Center St Louis, Missouri, United States

View all 39 locations

View Trial Details

Completed

An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus Infection

NCT03361956

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: The Office of Franco Felizarta, MD Bakersfield, California, United States

Orlando Immunology Center Orlando, Florida, United States

Rush University Medical Center Chicago, Illinois, United States

Tulane Medical Center (TMC) New Orleans, Louisiana, United States

View all 76 locations

View Trial Details

Completed

HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-Infection

NCT02660905

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Chronic Disease, +26 more
Locations: The Ottawa Hospital, General Campus Ottawa, Ontario, Canada

The Research Institute of the McGill University Health Centre Montreal, Quebec, Canada

View Trial Details

Completed

Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders

NCT00704106

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Stanford University Medical Center Palo Alto, California, United States

San Jose Gastroenterology San Jose, California, United States

San Jose Gastroenterology San Jose, California, United States

Asian Village Medical Clinic Chicago, Illinois, United States

View Trial Details

Completed

Comparing Brief Alcohol Interventions For HIV-HCV Co-infected Persons

NCT02316184

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Butler Hospital Providence, Rhode Island, United States

Miriam Hospital Providence, Rhode Island, United States

View Trial Details

Completed

Pegylated Interferon(Peg-IFN) in Reducing Relapse Rate in Patients After Discontinuation of NUC Therapy

NCT02594293

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Wuhan Seventh People's Hospital Wuhan, Hubei, China

Changzhou Third People's Hospital Changzhou, Jiangsu, China

First Affiliated Hospital of Zhejiang University Hangzhou, Jiangsu, China

People's Hospital of Jiangsu Province Nanjing, Jiangsu, China

View all 19 locations

View Trial Details

Completed

Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western Kenya

NCT01878435

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +30 more
Locations: Gem and Asembo Area Gem and Asembo Area, Siaya County, Kenya

View Trial Details

Completed

Study of Telemedicine Stress Management and Lifestyle Group Intervention for HCV Patients

NCT04198584

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Completed

A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses

NCT02434848

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +14 more
Locations: Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust Sheffield, South Yorkshire, United Kingdom

View Trial Details

Hepatitis, Viral, Human

Hepatitis, Viral, Human trial results

Related conditions